Seeking Alpha

Orexigen Therapeutics, Inc. (OREX)

()

News & PR
Market Currents

Buzz
Twitter: OREX

Business Intelligence
Transcripts
Events
Key Developments

Analysis - Latest Articles by most recent | most commented

Insider Buying Bodes Well For Orexigen

Nov 26, 2009 • Ruthanne Williams Roussel • 5 Comments
Amylin Takes Lead in Obesity Race

Nov 3, 2009 • Zacks.com • Comment!
Don't Expect Amylin to Eat the Obesity Market's Lunch

Nov 2, 2009 • Ruthanne Williams Roussel • 11 Comments
19 'Babies with Bathwater' and 1 'Dog with Fleas' Stocks for the Week

Oct 26, 2009 • J Clinton Hill • 9 Comments
FDA Calendar Extreme Trades: 85 Single Digit Stocks

Oct 14, 2009 • Mike Havrilla • 4 Comments
Why Orexigen's Empatic News Is Good

Oct 2, 2009 • Ruthanne Williams Roussel • 6 Comments
Surviving Wednesday's Wild Ride in Healthcare and Biotech

Oct 1, 2009 • M. E. Garza • 1 Comment
What to Look for in Orexigen's Empatic Data Release

Sep 30, 2009 • Ruthanne Williams Roussel • Comment!
Investing in the Obesity Drug Basket

Sep 21, 2009 • Michael Murphy • 14 Comments
Biotech Busy with Bevy of Small Deals

Sep 12, 2009 • The Burrill Report • 1 Comment
Vivus: A One Trick Pony

Sep 11, 2009 • Ruthanne Williams Roussel • 11 Comments
Cramer Likes Orexigen: Should You?

Aug 18, 2009 • Ruthanne Williams Roussel • 4 Comments
Orexigen Therapeutics: Expect Fat Gains This Year

Jul 27, 2009 • The Inflection Point • 5 Comments
Arena's Edge in the Obesity Drug Race

Jul 26, 2009 • Beacon Asset Managers • 4 Comments
VC Financings Boost Interest in Biotech

Jul 24, 2009 • The Burrill Report • Comment!
Five Small-Cap Weight Loss Trades

Jul 22, 2009 • Mike Havrilla • Comment!
Extreme FDA Trades: 20 Stocks Under 5 Bucks

Jul 21, 2009 • Mike Havrilla • 3 Comments
Monday Options Update: HGSI, OREX, EWJ & GE

Jul 20, 2009 • Andrew Wilkinson • 3 Comments
FDA Calendar Updates: Spectrum, Labopharm, Human Genome Sciences, Orexigen, Trinity

Jul 20, 2009 • Mike Havrilla • 1 Comment
Vivus: Obesity Experimental Drug Has Promising Outlook

Jul 8, 2009 • Penn Bioinvestor • 8 Comments
Extreme FDA Trades: Another 18 Stocks Under 5 Bucks

Jul 5, 2009 • Mike Havrilla • 2 Comments
30 Possible Pandemic Profit Plays: Bullish Biotech and Drug Stocks to Watch

Jun 28, 2009 • Marco Hickey • 1 Comment
NeuroSearch: Experimental Obesity Drug to Begin Phase 3 Trials

Jun 10, 2009 • Mike Havrilla • 1 Comment
Bio Medical Stock Sector is Where the Action Is

Jun 9, 2009 • M. E. Garza • Comment!
Pending Clinical Trial Results: Ten Extreme Trades

May 14, 2009 • Mike Havrilla • 8 Comments
FDA, Clinical Trial Calendars: Nine 'Cash Plus Catalyst' Trades

May 10, 2009 • Mike Havrilla • Comment!
Orexigen's Contrave: Generic Would Be No Cheaper

Apr 5, 2009 • Ruthanne Williams Roussel • 10 Comments
Q1 2009 Biotech Roundup: The Good, the Bad and the Ugly

Apr 2, 2009 • Mark Cifra • 5 Comments
Arena, The Aftermath

Apr 2, 2009 • Ruthanne Williams Roussel • 11 Comments
Arena's New Obesity Drug: Safe, But Not Too Efficacious

Mar 31, 2009 • Ruthanne Williams Roussel • 8 Comments
Three Ways to Play Arena Pharmaceuticals

Mar 18, 2009 • Ruthanne Williams Roussel • 4 Comments
Take Advantage of Market Confusion to Buy Orexigen Therapeutics

Mar 17, 2009 • Ruthanne Williams Roussel • 2 Comments
Arena Pharmaceuticals: Near Term Gamble May Be Worth It

Mar 10, 2009 • David White • 33 Comments
Biopharma: Instead of M&A, Think P&A

Mar 4, 2009 • Mike Huckman • 2 Comments
Vivus: A Bet on Well-Funded, Late-Stage Pipeline

Mar 4, 2009 • Mike Havrilla • 4 Comments
SAC Capital Portfolio Update: 37 13G Filings

Jan 15, 2009 • Market Folly • Comment!
Healthcare Investing: A Calendar of Expected Clinical Trial Results and Some Near Term Catalysts

Jan 12, 2009 • Mike Havrilla • 1 Comment
Canaccord Adams on Four Likeliest Economic Scenarios for 2009

Jan 7, 2009 • FP Trading Desk • 5 Comments
Fast Money Recap - Bullish on Biotech (1/5/09)

Jan 6, 2009 • SA Editor Miriam Metzinger • Comment!
Weekly Wrap-Up and Preview: December 15-19

Dec 16, 2008 • Tycoon Report • Comment!
Five Presentations from the Recent Biotech Investment Conference

Sep 5, 2008 • Mike Huckman • Comment!

Orexigen Therapeutics, Inc. (OREX)

Analysis - Latest Articles by most recent | most commented

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers